Westmount Partners’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.61M Hold
77,755
0.79% 23
2026
Q1
$1.91M Sell
77,755
-1,668
-2% -$39.5K 0.47% 49
2025
Q4
$1.97M Sell
79,423
-4,266
-5% -$113K 0.49% 47
2025
Q3
$2.36M Sell
83,689
-2,310
-3% -$62.6K 0.61% 36
2025
Q2
$2.14M Sell
85,999
-1,890
-2% -$53.2K 0.59% 39
2025
Q1
$2.73M Sell
87,889
-2,445
-3% -$81.5K 0.83% 25
2024
Q4
$2.85M Sell
90,334
-1,799
-2% -$85.4K 0.87% 25
2024
Q3
$5.34M Sell
92,133
-1,645
-2% -$80.8K 1.61% 14
2024
Q2
$3.73M Sell
93,778
-1,917
-2% -$76K 1.23% 15
2024
Q1
$4.02M Sell
95,695
-1,830
-2% -$71.4K 1.45% 14
2023
Q4
$3.74M Sell
97,525
-2,135
-2% -$71.1K 1.53% 12
2023
Q3
$3.07M Sell
99,660
-1,920
-2% -$66.3K 1.35% 13
2023
Q2
$3.21M Sell
101,580
-1,735
-2% -$59.5K 1.4% 14
2023
Q1
$3.77M Sell
103,315
-6,450
-6% -$226K 1.74% 11
2022
Q4
$3.25M Buy
+109,765
New +$3.53M 1.69% 11

Other funds holding ASTH

Westmount Partners's ASTH Position: Q2 2026 in Review

Westmount Partners held its Astrana Health (ASTH) position steady in Q2 2026 at 77,755 shares worth $3.61M. The position accounts for 0.79% of the portfolio, ranked #23.

Westmount Partners first reported a position in ASTH in Q4 2022 and has held it in 15 quarters since. The position peaked at $5.34M in Q3 2024. 210 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Westmount Partners held 77,755 shares of Astrana Health worth $3.61M as of Q2 2026.
  • Westmount Partners left its Astrana Health share count unchanged in Q2 2026.
  • Astrana Health made up 0.79% of Westmount Partners's portfolio in Q2 2026, its #23 holding.
  • Westmount Partners first reported a position in Astrana Health in Q4 2022 and has held it in 15 quarters since.
  • Westmount Partners's Astrana Health position peaked at $5.34M in Q3 2024.
  • 210 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Westmount Partners's 13F filing for Q2 2026, filed 7 Jul 2026.